![Stock Market Today: Dow in 4th weekly win as data puts September rate cut in play](https://i-invdn-com.investing.com/news/LYNXMPEB450HY_S.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1035 | 956 | 1101 | 1108 | 1312 | 1553 |
Fund Return | 3.53% | -4.39% | 10.06% | 3.48% | 5.59% | 4.5% |
Place in category | 59 | 59 | 61 | 32 | 56 | 25 |
% in Category | 37 | 37 | 40 | 31 | 74 | 78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tachlit TTF S&P 500 | 1.31B | 19.21 | 15.20 | 13.41 | ||
Tachlit TTF S&P 500 Hedged | 1.19B | 14.28 | 7.35 | - | ||
Meitav 20 80 | 1.11B | 2.31 | 1.58 | - | ||
Tachlit TTF NASDAQ 100 Hedged | 654M | 16.34 | 8.46 | - | ||
Meitav Bond Portfolio + 30 | 604.98M | 3.97 | 3.33 | 3.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
More Israel Equities | 1.38B | 4.94 | 5.21 | - | ||
Yelin Lapidot Equity | 960.95M | 5.58 | 0.62 | 7.49 | ||
MTF TA 125 | 788.79M | 3.49 | 3.47 | 4.55 | ||
IL0051275761 | 740.06M | 7.25 | 3.91 | - | ||
KESEM KTF Tel Aviv 125 | 665.15M | 3.53 | 3.45 | 4.55 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Teva | IL0006290147 | 5.57 | 6,174 | +1.71% | |
NICE Ltd | IL0002730112 | 5.55 | 66,690 | +0.14% | |
Leumi | IL0006046119 | 5.14 | 3,340 | -0.33% | |
Bank Hapoalim | IL0006625771 | 5.04 | 3,520 | -0.42% | |
Discount | IL0006912120 | 4.99 | 2,035 | -0.73% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review